With the objective of gathering the information on cardiovascular patients and those on blood thinning medication to facilitate monitoring and medication guidelines, a system has been created that uses GPRS on mobile terminals.
The President of the Madrid Association of Cardiovascular and Anti-Coagulant Patients (AMAC), Juan Manuel Ortíz Carranza, has created and designed eTAO, a project that seeks to gather information for the self-monitoring of patients on blood thinners that functions via GPRS communication with mobile terminals.
“The pilot project consists of integrating different technologies in the market to obtain a messaging service to mobile terminals that makes it possible to facilitate monitoring and medication guidelines. The mobile telephone terminal will have an IT application able to manage the information received and display it on a graphic interface. Said information will be sent over the network with all the safety guarantees used in the handling of health information sent over mobile and fixed networks,” explained Ortíz Carranza.
The health security protocols needed to safeguard the content will implemented on a remote administration server connected to a broadband network with remote access via a code so that healthcare professionals at each hospital can access it and see the patient’s INR data and thus administer their treatment through the mobile terminal.
M-Health has become synonymous with equality in the health sector and yet in Latin America it hasn’t yet been supported by political will.
Accessibility, interoperability, exchange and interconnection make it possible for patients with different resources to get better quality care. So: can M-health be developed in Latin America?
With the objective of defining the challenges for mobility in e-Health, at Futurecom 2013, a conference: “M-Health: the Intelligent Connection of Health and Mobility” was organized where successful case studies and trends in Brazil were discussed.
With the objective of supporting innovation and protecting users, the Food and Drug Administration of the USA has published a guide for developers of medical apps.
The FDA (Food and Drug Administration) has announced that it will begin to regulate medical applications that work with smartphones. As part of this initiative, the American agency has published a guide for developers of health apps.
The agency stated that it intends to focus its regulatory oversight on applications that might present a risk to patients if they don’t work properly.
“Some mobile applications present minimal risks to consumers or patients but others may cause considerable danger if they don’t work properly. The regulations defined by the FDA protect patients and encourage innovation,” said Doctor Jeffrey Shuren, the Director of the Center for Health Devices and Radiology at the FDA.
Although the agency clarified that it will not regulate sale or consumption, the oversight will be focused on applications that are designed to be used as an accessory to a regulated medical device. For example, this would include an application that allows health professionals to make a specific diagnosis through the visualization of a medical image from a PACS system on a smartphone or mobile tablet. It would also address those that are aimed at transforming a mobile platform into a regulated medical device, for example an application that can make a smartphone into an electrocardiogram machine (ECG) to detect abnormal heart rhythms or to determine whether a patient is suffering a heart attack.
The mHealth Grand Tour is an opportunity to help demonstrate innovative solutions to the challenges of managing diabetes.
The GSMA mHealth Grand Tour kicked off at the Autoworld Museum in Brussels, Belgium, on September 5. Over the next 12 days, six teams of cyclists, all of them living with diabetes, will travel 1,304 miles through several countries in Europe, arriving in Barcelona, Spain on September 18.
“There are 55 million people living with diabetes in Europe, and about 10 percent of the overall EU annual healthcare expenditure is being spent on diabetes,” said Michael O’Hara, chief marketing officer of the GSMA, in a press release.
A key aspect of the cycling tour is the fact that the riders will be equipped with mHealth tools to monitor their blood glucose levels.
“GSMA research, developed in partnership with PwC, has already shown that mHealth can save 5 million people in the EU from being at risk of developing diabetes by 2017. The mHealth Grand Tour will highlight how mobile technology can support diabetes prevention, diagnosis and treatment by increasing the reach and accessibility of healthcare services, cutting the cost of care and minimizing the impact of the illness on people’s lives.”
The Hospital Nacional de Parapléjicos de Toledo has developed a therapeutic mHealth tool that helps patients to perform rehabilitation exercises on their upper limbs from home.
The system, developed by the Hospital Nacional de Parapléjicos de Toledo and the multinational technology company Indra combines virtual reality and movement training in real time to help home motor rehabilitation for upper limbs – shoulder, arm, forearm and hand.
The main objective of the “Toyra” tool is to help patients continue with rehabilitation treatment after leaving the hospital. Furthermore, it gathers information that helps to carry out clinical tests and exercises.
It thus makes it possible to analyze results in an individualized manner because it provides an electronic therapeutic management and rehabilitation platform. In fact, the data obtained can be integrated into the patient’s electronic health record.
The tool, which has been implemented at different centers in the Spanish city since 2011, uses motion capture techniques with inertial sensors and via the Microsoft Kinect device. The recording devices also connect to the interactive therapy station sending the system the locations and positions it records to recreate on screen the exercises the patient carries out.
In the first edition of the event, the hackathon projects will be focused on Ghana, India, Thailand and Peru
The Development NGO (DNGO) Anesvad is organizing the first edition of Apps4Health, a social hackathon that will gather 60 mHealth applications developers on September 28th.
The objective of Apps4Health is to design five applications focused on mHealth issues with open source coding so that they can be implemented and reused.
The areas selected by the DNGO are: Infant Survival and Safe Motherhood in Ghana; the Elimination of Leprosy in India; Combatting Dengue Fever in Peru; and the Fight Against People Trafficking in Thailand.